Novel Mn(II) Quinaldinate Complexes With Halogenated Imidazo[1,2‐a]pyridine and Memantine: Synthesis, Spectroscopic Studies, and Selective Pro‐Apoptotic and Pro‐Oxidative Activity in Cancer Cells
ChemMedChem · 26.11.2026 · 21 (22)
DOI: 10.1002/cmdc.70578 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 16.11.2026. Verfasst von Tomasz Mazur und 6 weiteren Autor:innen. Die Arbeit nennt 81 Literaturangaben.
Abstract (Originalsprache)
Three novel Mn(II) complexes incorporating quinaldinate and biologically relevant N ‐donor ligands—halogenated imidazo[1,2‐a]pyridine derivatives—were synthesized and comprehensively characterized in the solid state by single‐crystal X‐ray diffraction, FT‐IR, Raman spectroscopy, and thermal analysis. The investigated compounds include two unprecedented one‐dimensional coordination polymers, [Mn 2 (6‐Brimpy) 2 (QA) 4 ] n ( 1 ) and [Mn 2 (6‐Climpy) 2 (QA) 4 ] n ( 2 ), and the mononuclear complex [Mn(QA) 3 ](H 2 O)⋅(mem) ( 3 ). FT‐IR studies in DMSO suggested the persistence of coordination species derived from compounds 1–3, while allowing for changes in solution speciation. UV–vis and emission measurements revealed ligand‐centered absorption and pronounced luminescence, indicating that the obtained systems combine selective biological activity with promising photophysical properties. Biological evaluation against metastatic melanoma (1205‐Lu), glioblastoma (T98G), and normal dermal fibroblasts (NHDF) demonstrated moderate but selective anticancer activity, with the strongest effect observed for complex 2 toward 1205‐Lu cells, while all compounds remained essentially nontoxic toward NHDF fibroblasts. Mechanistic studies revealed a concentration‐dependent increase in caspase‐3 activity and malondialdehyde levels in melanoma cells, indicating apoptosis induction accompanied by oxidative stress and lipid peroxidation. Importantly, the free ligands alone did not exhibit significant anticancer activity, demonstrating that coordination to Mn(II) is essential for the emergence and enhancement of the observed biological effects.
Zitieren
APA
Mazur, T., Rydz, M., Machura, B., Środa‐Pomianek, K., Wesołowska, O., Palko‐Łabuz, A., & Bieńko, D. (2026). Novel Mn(II) Quinaldinate Complexes With Halogenated Imidazo[1,2‐a]pyridine and Memantine: Synthesis, Spectroscopic Studies, and Selective Pro‐Apoptotic and Pro‐Oxidative Activity in Cancer Cells. ChemMedChem, 21(22). https://doi.org/10.1002/cmdc.70578
Vancouver
Mazur T, Rydz M, Machura B, Środa‐Pomianek K, Wesołowska O, Palko‐Łabuz A, et al. Novel Mn(II) Quinaldinate Complexes With Halogenated Imidazo[1,2‐a]pyridine and Memantine: Synthesis, Spectroscopic Studies, and Selective Pro‐Apoptotic and Pro‐Oxidative Activity in Cancer Cells. ChemMedChem. 2026;21(22). doi:10.1002/cmdc.70578
BibTeX
@article{Mazur2026,
author = {Mazur, Tomasz and Rydz, Magdalena and Machura, Barbara and Środa‐Pomianek, Kamila and Wesołowska, Olga and Palko‐Łabuz, Anna and Bieńko, Dariusz},
title = {Novel Mn(II) Quinaldinate Complexes With Halogenated Imidazo[1,2‐a]pyridine and Memantine: Synthesis, Spectroscopic Studies, and Selective Pro‐Apoptotic and Pro‐Oxidative Activity in Cancer Cells},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {22},
doi = {10.1002/cmdc.70578}
}
EUVIMED